Experimental feature

Listen to this article

Experimental feature

Just a short blog, as it looks like we’re going to have to make our own fun today and I can’t tell you about that yet – except to say we’ve got some good Northern Rockery in the works.

Otherwise, stand by for a concession of defeat around lunchtime from Barclays on ABN Amro (”Veni, vidi, Varley. He came, he saw, he almost certainly failed to conquer” as Lombard so nicely put it on Thursday). Jeremy Warner was on form in the Indie this morning. “The only real positive that Barclays takes away from months of trying is that in the end it resisted the temptation to overpay,” he wrote. “In all other respects, its chosen strategy lies in tatters.”

WH Ireland, the small stockbroker, says it had received a number of takeover approaches. Sarah Spikes has established that one of the approaches is from Formation Group.

A company called CVS, which owns vet surgeries, says it plans to raise £92.7m through an Aim float. Could be a dog, as one of my colleagues said.

EasyJet, the low-cost airline, says it expects to beat its previous profit guidance, thanks to a one-off £11m gain from its investment in The Airline Group, the consortium which runs the UK’s air traffic control system.

Comment on our coverage

About this blog

Receive this blog for free by email

See previous blogs

Get alerts on Columnists when a new story is published

Copyright The Financial Times Limited 2019. All rights reserved.

Comments have not been enabled for this article.

Follow the topics in this article